VRTX Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated (VRTX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $3.1M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| McKechnie Duncan | EVP, Chief Commercial Officer | Sell 10b5-1 | 1,541 | $519.00 | $799.8K | 11,001 −12.3% of holding | |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell 10b5-1 | 1,500 | $524.99 | $787.5K | 45,321 −3.2% of holding | |
| Liu Joy | EVP and Chief Legal Officer | Sell 10b5-1 | 828 | $502.71 | $416.2K | 19,131 −4.1% of holding | |
| Bozic Carmen | EVP and CMO | Sell 10b5-1 | 596 | $482.50 | $287.6K | 15,337 −3.7% of holding | |
| Bozic Carmen | EVP and CMO | Sell 10b5-1 | 1,020 | $462.17 | $471.4K | 15,933 −6% of holding | |
| Bozic Carmen | EVP and CMO | Sell 10b5-1 | 4,062 | $450.00 | $1.8M | 16,953 −19.3% of holding | |
| Bozic Carmen | EVP and CMO | Sell 10b5-1 | 1,745 | $450.00 | $785.3K | 21,015 −7.7% of holding | |
| Liu Joy | EVP and Chief Legal Officer | Sell 10b5-1 | 828 | $439.91 | $364.2K | 19,959 −4% of holding | |
| Bozic Carmen | EVP and CMO | Sell 10b5-1 | 1,974 | $450.00 | $888.3K | 22,760 −8% of holding | |
| Bozic Carmen | EVP and CMO | Sell 10b5-1 | 1,354 | $453.45 | $614.0K | 24,734 −5.2% of holding | |
| Bunnage Mark E. | EVP, Chief Scientific Officer | Sell 10b5-1 | 33 | $453.45 | $15.0K | 7,284 −0.5% of holding | |
| Bozic Carmen | EVP and CMO | Sell 10b5-1 | 6,988 | $450.00 | $3.1M | 26,088 −21.1% of holding | |
| Bhatia Sangeeta N. | Director | Sell 10b5-1 | 318 | $423.73 | $134.7K | 4,924 −6.1% of holding | |
| Liu Joy | EVP and Chief Legal Officer | Sell 10b5-1 | 1,104 | $425.02 | $469.2K | 20,729 −5.1% of holding | |
| Liu Joy | EVP and Chief Legal Officer | Sell 10b5-1 | 978 | $449.17 | $439.3K | 21,833 −4.3% of holding | |
| Bozic Carmen | EVP and CMO | Sell 10b5-1 | 2,329 | $450.95 | $1.1M | 33,076 −6.6% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.